Compare VIOT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIOT | NTRB |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.0M | 72.6M |
| IPO Year | 2018 | 2019 |
| Metric | VIOT | NTRB |
|---|---|---|
| Price | $1.90 | $7.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 134.8K |
| Earning Date | 08-27-2026 | 09-04-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,651.00 |
| Revenue This Year | N/A | $4,584.65 |
| Revenue Next Year | $4.78 | $89.09 |
| P/E Ratio | $3.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $2.80 |
| 52 Week High | $3.61 | $9.19 |
| Indicator | VIOT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 68.44 | 58.25 |
| Support Level | $0.82 | $3.68 |
| Resistance Level | $1.88 | N/A |
| Average True Range (ATR) | 0.14 | 0.91 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 79.56 | 37.12 |
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.